Cervical pessary for reducing bleeding in placenta previa
Part of Women’s health & pregnancy clinical trials.
This study tests whether a silicone cervical pessary can help reduce bleeding in pregnant women with placenta previa (a low-lying placenta near the cervix). You may qualify if you are between 20 and 30 weeks pregnant and have been diagnosed with this condition.
Summary written for real people, not researchers, by Clin2.
Who can take part
- 18 to 45 years old
- Pregnant with a single baby
- Diagnosed with placenta previa (total or marginal) or a low-lying placenta less than 20 mm from the cervix opening between 20 and 30 weeks of pregnancy
- No major fetal abnormalities detected on ultrasound
- No silicone allergy, active infection, or bleeding at enrollment
- No prior cervical cerclage or pessary already in place
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares two medications, tranexamic acid and vasopressin, given during a planned C-section to reduce bleeding. The goal is to find the safer and more effective option for women with placenta previa.
This trial compares delivering at 36 weeks versus 37 weeks for pregnant women with a condition called placenta previa with accreta, where the placenta covers the cervix and grows too deeply into the womb. The goal is to find the best time for delivery to improve safety for both mother and baby.
This trial tests whether wearing a silicone ring (pessary) around the cervix can help prevent early birth in women who have had a previous premature baby or late miscarriage. It aims to see if the device is safe and effective for reducing the risk of preterm labor.
This study looks at how the thickness of the placenta affects pregnancy outcomes in women with placenta previa. It may help doctors better manage pregnancies with this condition.
This trial tests if placing a stitch in the cervix (cerclage) between 24 and 27 weeks of pregnancy can help prevent preterm birth in women whose cervix is short. It may be an option for those who find out late in pregnancy that they are at risk.
This trial studies whether tranexamic acid can prevent heavy bleeding after a planned or urgent cesarean delivery in people with placenta previa. If you qualify, you may receive the study drug to help your body keep blood loss lower during and after surgery.
Hear when a new Placenta Previa trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.